OCRELIZUMAB

ocrelizumab 300 mg/10 mL injection, 10 mL vial

OCRELIZUMAB (11237K)

ocrelizumab 300 mg/10 mL injection, 10 mL vial
11237K
Body System:
Manner of administration:Injection
Private
S100 HSD Private
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 9523)

Indication: Multiple sclerosis
Treatment phase: Initial treatment

Restriction (Streamlined authority code: 9635)

Indication: Multiple sclerosis
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 2 # of repeats: 0 DPMQ: $16,705.24 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Ocrevus